We report a 25‐year‐old man with bradycardia after administration of ophthalmic timolol.
The patient was asymptomatic, and his bradycardia resolved after stopping the eye drop. He …

Background To evaluate risk factors for subject withdrawals from multicenter clinical trials
evaluating glaucoma medications. Methods An analysis of prospective, randomized …

Beta-adrenergic receptor blockers are an important class of drugs in the management of
patients with cardiovascular diseases. Patients with multiple sclerosis have a higher risk of …

Elevated intraocular pressure (IOP) causes structural changes in the optic nerve head in
glaucoma patients. IOP reduction is clearly the only available treatment that has been …

Myopia (near-sightedness) has become a significant public health concern, as its
prevalence continues to increase in the United States and around the world. Further, myopia …

Importance: Nasolacrimal occlusion (NLO) is effective in reducing systemic absorption of
eye drop medication but it is difficult and often performed poorly. We propose an alternative …

1. SUMMARY.…………………………………………………………………………………… 1 2.
INTRODUCTION 2.1 Background …

Purpose: To present results of contemporary multimodal ophthalmic imaging in a case of
maternally inherited diabetes and deafness (MIDD) and a literature review of MIDD …

Drug-induced bradycardia is a common adverse effect as well as a desired effect of
therapeutic treatment. Interactions between drugs in patients who may be taking many …